Bea S, Son H, Bae JH, Cho SW, et al. Risk of thyroid cancer associated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A population-based cohort study. Diabetes Obes Metab 2023 Sep 21. doi: 10.1111/dom.15292.
PMID: 37735822